JPMorgan $11.47M Capped Buffered Notes Offering
JPMorgan Chase Financial Company LLC priced $11,467,000 of Capped Buffered Return Enhanced Notes linked to the S&P 500® Index on April 16, 2026, expected to settle on or about April 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC priced $11,467,000 of Capped Buffered Return Enhanced Notes linked to the S&P 500® Index on April 16, 2026, expected to settle on or about April 21, 2026. The notes pay 1.05× any Index appreciation up to a Maximum Return of 18.85% and provide a 30.00% buffer against index declines; if the Index falls more than 30.00% at the Observation Date, investors lose 1% of principal for each additional 1% decline (up to a potential loss of 70.00% of principal). The Initial Value was 7,041.28 (closing level on the Pricing Date). Notes are unsecured obligations of JPMorgan Financial and are fully and unconditionally guaranteed by JPMorgan Chase & Co.; payments are subject to both entities' credit risk. The notes are not FDIC insured and have CUSIP 46660RWQ3.
Insights
Structured note mixes modest upside (cap) with a significant downside buffer trade-off.
The structure offers 1.05x upside exposure to the S&P 500 up to an 18.85% cap, with a 30.00% downside buffer that protects against losses up to that threshold. The economics embed selling commissions and hedging/structuring costs; the estimated value at pricing was $986.70 per $1,000 note, below the issue price.
Key dependencies include the S&P 500 closing level on the Observation Date and the creditworthiness of JPMorgan Financial and JPMorgan Chase & Co. Secondary market liquidity is limited and repurchase valuations may be below original issue price.
Tax treatment is uncertain; issuer expects “open transaction” treatment but alternate IRS positions could change timing/character of income.
The issuer and special counsel intend to treat the notes as open transactions for U.S. federal income tax purposes, which would generally produce long-term capital gain/loss on sale or maturity if held over a year. The pricing supplement warns the IRS or a court might adopt alternative treatments (for example, contingent payment debt instrument treatment) that could materially and adversely affect timing and character of income.
Non-U.S. holders should note the issuer’s view on Section 871(m); the issuer’s determination is not binding on the IRS. Consult a tax adviser.
Key Figures
Key Terms
Upside Leverage Factor financial
Buffer Amount financial
open transactions regulatory
Section 871(m) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the key terms of the JPM capped buffered notes (JPM)?
How is payment at maturity calculated for JPM's notes?
What credit and liquidity risks apply to JPMorgan’s notes?
What was the estimated value versus the issue price for the notes?
How are the notes treated for U.S. federal income tax purposes?
AI-generated analysis. How Rhea-AI works. Not financial advice.